Merck MRK announced that the FDA has accepted its supplemental new drug application (sNDA) seeking approval of its oral HIF-2α inhibitor, Welireg (belzutifan), for a new indication. The sNDA is ...
1 Day SNDA -1.84% DJIA -0.32% Russell 2K -0.30% Health Care/Life Sciences -0.52% ...
Scilex (SCLX) announced that it will be filing today of a Supplemental New Drug Application, SNDA, with the FDA for ELYXYB in acute pain indication. “We are well positioned to broaden the ELYXYB ...
At Sonida Senior Living, a filing with the SEC revealed that on Friday, Michael Simanovsky bought 42,111 shares of SNDA, at a cost of $21.32 each, for a total investment of $897,835. So far ...
For example, the Sonida Senior Living, Inc. (NYSE:SNDA) share price has soared 146% in the last 1 year. Most would be very happy with that, especially in just one year! On the other hand ...